AU2001258876A1 - External application for enhancing the skin permeability of the active components therein - Google Patents

External application for enhancing the skin permeability of the active components therein

Info

Publication number
AU2001258876A1
AU2001258876A1 AU2001258876A AU5887601A AU2001258876A1 AU 2001258876 A1 AU2001258876 A1 AU 2001258876A1 AU 2001258876 A AU2001258876 A AU 2001258876A AU 5887601 A AU5887601 A AU 5887601A AU 2001258876 A1 AU2001258876 A1 AU 2001258876A1
Authority
AU
Australia
Prior art keywords
enhancing
active components
external application
skin permeability
beta
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001258876A
Inventor
Byung Young Kang
Mu Sung Kim
Dong Chul Lee
Jang Young Lee
Sung Gu Lee
Eui Seok Shin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pacific Corp
Original Assignee
Pacific Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pacific Corp filed Critical Pacific Corp
Publication of AU2001258876A1 publication Critical patent/AU2001258876A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • A61K8/602Glycosides, e.g. rutin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66Enzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/676Ascorbic acid, i.e. vitamin C
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/70Biological properties of the composition as a whole

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present invention relates to a composition for external application enhancing the skin absorption of the active components infused in the composition, more specifically relates to an external application having enhanced skin permeability of the active components by using protease stabilized by beta-1,3-glucan branched with beta-1,6-linkage as an agent for enhancing the skin permeability to weaken the wall properties of the corneous layer.
AU2001258876A 2000-05-16 2001-05-16 External application for enhancing the skin permeability of the active components therein Abandoned AU2001258876A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR1020000026086A KR100338327B1 (en) 2000-05-16 2000-05-16 External application for enhancing the skin permeability of the active components therein
KR0026086 2000-05-16
PCT/KR2001/000788 WO2001087255A1 (en) 2000-05-16 2001-05-16 External application for enhancing the skin permeability of the active components therein

Publications (1)

Publication Number Publication Date
AU2001258876A1 true AU2001258876A1 (en) 2001-11-26

Family

ID=19668725

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001258876A Abandoned AU2001258876A1 (en) 2000-05-16 2001-05-16 External application for enhancing the skin permeability of the active components therein

Country Status (9)

Country Link
US (1) US20040022753A1 (en)
EP (1) EP1282393B1 (en)
JP (1) JP5013648B2 (en)
KR (1) KR100338327B1 (en)
CN (1) CN1457253A (en)
AT (1) ATE308967T1 (en)
AU (1) AU2001258876A1 (en)
DE (1) DE60114801T2 (en)
WO (1) WO2001087255A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100338327B1 (en) * 2000-05-16 2002-08-07 주식회사 태평양 External application for enhancing the skin permeability of the active components therein
KR100447055B1 (en) * 2001-07-30 2004-09-04 주식회사 참 존 Technical procedure of modified Alternan production and enzyme stabilization
GB0128629D0 (en) * 2001-11-29 2002-01-23 Univ Sheffield Method
KR20030082765A (en) * 2002-04-18 2003-10-23 한국화학연구원 Transdermal drug delivery matrix type system contained hydroquinone and cosmetic ingredients
KR100507960B1 (en) * 2002-10-22 2005-08-19 (주)나노팜 Composition of removing corneum, method of preparing the same and cleansing composition including the same
CA2529953A1 (en) * 2003-06-23 2004-12-29 Transpharma Medical Ltd. Transdermal delivery system for cosmetic agents
JP4626202B2 (en) * 2003-07-16 2011-02-02 大正製薬株式会社 Piroxicam-containing external anti-inflammatory analgesic composition
DE102004010940B4 (en) 2004-03-05 2012-01-26 Erbe Elektromedizin Gmbh Neutral electrode for HF surgery
EP1609460A1 (en) * 2004-06-24 2005-12-28 The Procter & Gamble Company Skin care compositions comprising fatty material having a melting temperature range of 21-40 C
EP1778169A1 (en) * 2004-08-13 2007-05-02 Symrise GmbH & Co. KG Beta-(1,3)-beta-(1,4)-glucan as carrier for chemical substances
CN101072571A (en) * 2004-12-10 2007-11-14 爱尔康公司 Compositions for treatment of ear infections
WO2007119467A1 (en) * 2006-03-23 2007-10-25 Cosmed Pharmaceutical Co., Ltd. Percutaneous absorption promoting agent and percutaneous absorption preparation using the same
US20080160043A1 (en) * 2007-07-16 2008-07-03 Kim Moo-Sung Preparation method of beta-glucan from schizophyllum commune and composition for external application comprising the same
DE102009013469B4 (en) 2009-03-19 2014-04-17 Bubbles And Beyond Gmbh Preparation for external use
WO2011061144A2 (en) 2009-11-20 2011-05-26 Basf Se The present invention relates to the use of beta-(1, 3)- beta-(1, 4) glucan with an average molecular weight of from 5.000 to 150.000 da for the increase of synthesis of collagen

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61282313A (en) * 1985-06-06 1986-12-12 Nitto Electric Ind Co Ltd Enzyme-containing plaster
US5156846A (en) * 1989-02-23 1992-10-20 University Of Utah Percutaneous drug delivery system
JP2938916B2 (en) * 1990-01-10 1999-08-25 日本ケミカルリサーチ株式会社 Inhibitor of herpesvirus growth and inhibitor of recurrence after latent infection
JP3000488B2 (en) * 1991-03-07 2000-01-17 株式会社コーセー Cosmetics
JPH06321733A (en) * 1993-05-07 1994-11-22 Noevir Co Ltd Sheetlike pack agent and its production
US5441740A (en) * 1994-05-06 1995-08-15 Longevity Network. Ltd. Cosmetic composition containing alpha hydroxyacids, salicyclic acid, and enzyme mixture of bromelain and papain
JPH09176029A (en) * 1995-12-26 1997-07-08 Shigenobu Sakata Outer cortex function-stimulating and infection-preventing liquid and its production
CA2212314A1 (en) * 1996-08-02 1998-02-02 Institute For Advanced Skin Research Inc. Composition for enhancing hyaluronic acid productivity and method for preparing same
US6162419A (en) * 1996-11-26 2000-12-19 Nicholas V. Perricone Stabilized ascorbyl compositions
FR2761363B1 (en) * 1997-03-28 1999-11-26 Oreal PURIFYING SKIN POLYPEPTIDE AND ITS USE
DE69833000T2 (en) * 1997-09-26 2006-09-07 Noven Pharmaceuticals, Inc., Miami BIO-ADHESIVE COMPOSITIONS
FR2781668B1 (en) * 1998-07-31 2001-06-01 Oreal SKIN TREATMENT PROCESS AND PATCH FOR IMPLEMENTING THE PROCESS
KR100283848B1 (en) * 1999-03-19 2001-02-15 서경배 A method for preparation of stabilized enzymes or proteins and compositions for external application containing stabilized enzymes or proteins prepared thereby
KR100338327B1 (en) * 2000-05-16 2002-08-07 주식회사 태평양 External application for enhancing the skin permeability of the active components therein

Also Published As

Publication number Publication date
CN1457253A (en) 2003-11-19
ATE308967T1 (en) 2005-11-15
WO2001087255A1 (en) 2001-11-22
US20040022753A1 (en) 2004-02-05
DE60114801D1 (en) 2005-12-15
EP1282393A4 (en) 2004-03-31
EP1282393B1 (en) 2005-11-09
DE60114801T2 (en) 2006-11-23
KR20010104881A (en) 2001-11-28
JP5013648B2 (en) 2012-08-29
JP2004507458A (en) 2004-03-11
KR100338327B1 (en) 2002-08-07
EP1282393A1 (en) 2003-02-12

Similar Documents

Publication Publication Date Title
AU2001258876A1 (en) External application for enhancing the skin permeability of the active components therein
WO2006069998A3 (en) Glycopyrrolate in cosmetic preparations
WO2008152444A3 (en) Foamable waterless compositions with modulating agents
WO2002056861A3 (en) Syntactic deformable foam compositions and methods for making
CR8428A (en) ENDOPARASITICID AGENT FOR TOPICAL ADMINISTRATION
WO2008016664A3 (en) Compositions and methods for treating cancer with dacarbazine nanoemulsions
WO2007043057A3 (en) Compositions for nasal delivery
TW200710220A (en) Foamable alcohol compositions, systems and methods of use
ECSP067110A (en) DERIVATIVES OF 2-CARBAMIDA-4-FENILTIAZOL, ITS PREPARATION AND ITS APPLICATION IN THERAPEUTICS
MX2009012465A (en) Dimensionally stable solid rinse aid.
PT1169370E (en) POLYURETHANE SOLUTIONS CONTAINING STRUCTURAL UNITS OF ALCOXYSILAN.
AR048681A1 (en) LIQUID WHITENING COMPOSITIONS
AU5792399A (en) Stable ascorbic acid preparation for topical use
TW200503640A (en) Accelerator for mineral absorption and its usage
TW200724159A (en) Stable emulsion composition
WO2008039472A3 (en) Stabilizing compositions for antibiotics and methods of use
WO2009031318A1 (en) Preparation for external application comprising analgesic/anti-inflammatory agent
WO2007144521A3 (en) Cosmetic composition for topical use comprising wasabi
PL1868631T3 (en) Use of compounds inducing the synthesis of sirt proteins in or for the preparation of a cosmetic or pharmaceutical composition
TW200637585A (en) Improved cleansing composition
BRPI0410602A (en) oxygen barrier formulations
ATE538773T1 (en) PROSTAGLANDIN-BASED COMPOSITION AND METHOD FOR USE THEREOF
MY153899A (en) Compositions containing sesamin-class compound(s) and quercetin glycoside(s)
MXPA03010861A (en) Topical composition comprising an activated, trans-structured cosmetic bonding agent.
MX2009006549A (en) Quaternary ammonium compounds with novel mode of action for protection of wood structures.